Chronic Fatigue & Post-Viral Recovery Protocol
Chronic Fatigue & Post-Viral Recovery Protocol framework focused on consistent execution, practical monitoring, and safer progression.
Targeted protocol for chronic fatigue syndrome, post-viral fatigue (including long COVID), and ME/CFS. Addresses mitochondrial dysfunction, immune dysregulation, and neuroinflammation simultaneously.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
Chronic Fatigue & Post-Viral Recovery Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
6–12 months continuous; taper based on symptom response. No hard cycling limit for immune peptides.
Target Audience
ME/CFS patients, long COVID sufferers, post-viral fatigue, unexplained chronic fatigue with immune dysfunction
| Compound | Dose | Frequency |
|---|---|---|
| BPC-157 Vagal nerve repair, gut-brain axis restoration, systemic cytoprotection | 250–500 mcg | Twice daily |
| Thymosin Alpha-1 Restores NK cell activity and CD8+ cytotoxic T-cell function; corrects Th2 dominance | 1.5 mg | 5–7 days per month |
| NAD+ Critical for mitochondrial Complex I; severely depleted in ME/CFS; IV most effective | 500–1000 mg | Daily |
| MOTS-c Mitokine signaling restoring metabolic flexibility; AMPK activation in fatigued muscle | 5 mg | 3x per week |
| VIP Corrects autonomic dysregulation and POTS-like symptoms common in long COVID/CFS | 50 mcg | Twice daily |
Free Peptide Guide
Chronic Fatigue & Post-Viral Recovery Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned BPC-157 timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should Chronic Fatigue & Post-Viral Recovery Protocol run before reassessment?
A common window is 6–12 months continuous; taper based on symptom response. No hard cycling limit for immune peptides., with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with BPC-157 + Thymosin Alpha-1 execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
BPC-157 addresses gut dysbiosis (common in post-viral states) and vagal nerve inflammation underlying many CFS symptoms. Thymosin Alpha-1 corrects the immune dysregulation (elevated Th2/Treg with depressed NK and CD8+ cytotoxic function) characteristic of ME/CFS and long COVID. NAD+ replenishes the severely depleted NAD+/NADH ratio in chronic fatigue, restoring mitochondrial Complex I function. MOTS-c activates AMPK-driven metabolic recovery in fatigued mitochondria. VIP corrects the autonomic nervous system dysregulation (POTS, autonomic neuropathy) prevalent in long COVID.
Clinical Research
No clinical references were provided for this stack yet.
More Immune Support Stacks
Ankylosing Spondylitis & Axial Spondyloarthropathy Protocol
An adjunctive protocol for individuals with ankylosing spondylitis and axial spondyloarthropathy, targeting the IL-17/IL-23-driven enthesitis, progressive syndesmophyte formation, and the TNF-driven inflammatory cascade that cause irreversible spinal fusion.
Ankylosing Spondylitis & Axial Spondyloarthropathy Protocol
Anti-inflammatory and joint-protective peptide protocol for ankylosing spondylitis targeting spinal inflammation, syndesmophyte prevention, and preservation of spinal mobility.
Crohn's Disease & IBD Management Protocol
Peptide-based protocol targeting intestinal inflammation, barrier repair, and mucosal immune regulation for Crohn's disease and ulcerative colitis management.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
Chronic Fatigue & Post-Viral Recovery Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.